Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mental health
Pharma
Teva looks to peel back the onion on mental health: exec
The company is currently studying a long-acting version of olanzapine, an aging schizophrenia treatment that Eli Lilly markets as Zyprexa.
Zoey Becker
Dec 31, 2024 8:00am
AbbVie CLL survey shows emotional impact on patients of color
Dec 9, 2024 11:48am
Sun Pharma brightens up Ilumya promos with self-‘luv’ campaign
Jun 6, 2024 9:20am
Dexcom report links Type 2 diabetes to anxiety, depression
May 21, 2024 10:51am
Almirall drills home message about psoriasis' mental health toll
Oct 30, 2023 10:18am
Fierce 50: Health Equity honorees
Oct 2, 2023 4:00am
